Home/Filings/4/0000950170-25-083845

4//SEC Filing

Revelation Alpine, LLC 4

Accession 0000950170-25-083845

CIK 0001611115other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:13 PM ET

Size

41.7 KB

Accession

0000950170-25-083845

Insider Transaction Report

Form 4

Period: 2025-06-09

Omada Health, Inc.OMDA

Revelation Healthcare Fund II GP, L.P.

10% Owner

Transactions

Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Healthcare Fund IV GP, LLC

10% Owner

Transactions

Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)

REVELATION HEALTHCARE FUND II, L.P.

10% Owner

Transactions

Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)

Revelation Healthcare Fund IV GP, L.P.

10% Owner

Transactions

Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Alpine, LLC

10% Owner

Transactions

Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)

REVELATION ALPINE, L.P.

10% Owner

Transactions

Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Alpine GP, LLC

10% Owner

Transactions

Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Healthcare Fund II GP, LLC

10% Owner

Transactions

Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Revelation Healthcare Fund IV, L.P.

10% Owner

Transactions

Conversion
Common Stock
2025-06-09+469,222→ 492,886 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+456,184→ 802,849 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+2,439,265→ 3,095,306 total(indirect: See footnotes)
Conversion
Common Stock
2025-06-09+816,993→ 816,993 total(indirect: See footnotes)
Conversion
Series C Preferred Stock
2025-06-09−158,072→ 0 total(indirect: See footnotes)
→ Common Stock (158,072 underlying)
Conversion
Series C-1 Preferred Stock
2025-06-09−44,535→ 0 total(indirect: See footnotes)
→ Common Stock (44,535 underlying)
Conversion
Series E Preferred Stock
2025-06-09−266,615→ 0 total(indirect: See footnotes)
→ Common Stock (266,615 underlying)
Conversion
Series E Preferred Stock
2025-06-09−456,184→ 0 total(indirect: See footnotes)
→ Common Stock (456,184 underlying)
Conversion
Series D Preferred Stock
2025-06-09−2,161,265→ 0 total(indirect: See footnotes)
→ Common Stock (2,161,265 underlying)
Conversion
Series E Preferred Stock
2025-06-09−278,000→ 0 total(indirect: See footnotes)
→ Common Stock (278,000 underlying)
Conversion
Series D Preferred Stock
2025-06-09−816,993→ 0 total(indirect: See footnotes)
→ Common Stock (816,993 underlying)

Footnotes (7)

[F1]Each share of Series C Preferred Stock, Series C-1 Preferred Stock, Series D Preferred Stock and Series E Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date.
[F2]Shares held by Revelation Alpine, LLC.
[F3]Shares held by Revelation Healthcare Fund II, L.P.
[F4]Shares held by Revelation Healthcare Fund IV, L.P.
[F5]Shares held by Revelation Alpine, L.P.
[F6]Revelation Healthcare Fund II GP, LLC is the general partner of Revelation Healthcare Fund II GP, L.P., which is the general partner of Revelation Healthcare Fund II, L.P. Revelation Alpine GP, LLC is the general partner of Revelation Alpine, L.P. and the manager of Revelation Alpine, LLC. Revelation Healthcare Fund IV GP, LLC is the general partner of Revelation Healthcare Fund IV GP, L.P., which is the general partner of Revelation Healthcare Fund IV, L.P. Scott Halsted and Michael Boggs are the managing members of Revelation Healthcare Fund II GP, LLC, Revelation Alpine GP, LLC, and Revelation Healthcare Fund IV GP, LLC and in such capacity make investment and voting decisions on behalf of Revelation Alpine, LLC, Revelation Healthcare Fund II, L.P., Revelation Healthcare Fund IV, L.P. and Revelation Alpine, L.P.
[F7]Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act or for any other purpose.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Omada Health, Inc.

CIK 0001611115

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001910436

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 5:13 PM ET
Size: 41.7 KB

View on SEC.gov